Microbiología Medica
Instituto de Parasitología y Biomedicina López Neyra
Armilla, EspañaPublicacions en col·laboració amb investigadors/es de Instituto de Parasitología y Biomedicina López Neyra (20)
2024
-
The expression of immune response genes in patients with chronic Chagas disease is shifted toward the levels observed in healthy subjects as a result of treatment with Benznidazole
Frontiers in Cellular and Infection Microbiology, Vol. 14
2023
-
Differential expression profile of genes involved in the immune response associated to progression of chronic Chagas disease
PLoS Neglected Tropical Diseases, Vol. 17, Núm. 7
2021
-
A proportion of cd4+ t cells from patients with chronic chagas disease undergo a dysfunctional process, which is partially reversed by benznidazole treatment
PLoS Neglected Tropical Diseases, Vol. 15, Núm. 2, pp. 1-25
-
Differential Expression of Immune Response Genes in Asymptomatic Chronic Chagas Disease Patients Versus Healthy Subjects
Frontiers in Cellular and Infection Microbiology, Vol. 11
2020
-
Differential phenotypic and functional profile of epitope-specific cytotoxic CD8+ T cells in benznidazole-treated chronic asymptomatic Chagas disease patients
Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1866, Núm. 3
-
Immunological exhaustion and functional profile of CD8+ T lymphocytes as cellular biomarkers of therapeutic efficacy in chronic Chagas disease patients
Acta Tropica, Vol. 202
2019
-
A Parasite Biomarker Set for Evaluating Benznidazole Treatment Efficacy in Patients with Chronic Asymptomatic Trypanosoma cruzi Infection
Antimicrobial Agents and Chemotherapy, Vol. 63, Núm. 10
-
An observational longitudinal study to evaluate tools and strategies available for the diagnosis of Congenital Chagas Disease in a non-endemic country
Acta Tropica, Vol. 199
2018
-
Impact of benznidazole treatment on the functional response of Trypanosoma cruzi antigen-specific CD4+CD8+T cells in chronic Chagas disease patients
PLoS Neglected Tropical Diseases, Vol. 12, Núm. 5
2017
-
Expression of inhibitory receptors and polyfunctional responses of T cells are linked to the risk of congenital transmission of T. cruzi
PLoS Neglected Tropical Diseases, Vol. 11, Núm. 6
2016
-
A 12-mer repetitive antigenic epitope from Trypanosoma cruzi is a potential marker of therapeutic efficacy in chronic Chagas' disease
Journal of Antimicrobial Chemotherapy, Vol. 71, Núm. 7, pp. 2005-2009
2015
2014
2013
-
Benznidazole treatment reduces the induction of indoleamine 2,3-dioxygenase (IDO) enzymatic activity in Chagas disease symptomatic patients
Parasite Immunology, Vol. 35, Núm. 5-6, pp. 180-187
-
Risk factors and primary prevention of congenital chagas disease in a nonendemic country
Clinical Infectious Diseases, Vol. 56, Núm. 4, pp. 496-502
2012
-
Characterization of an immunodominant antigenic epitope from Trypanosoma cruzi as a biomarker of chronic Chagas' disease pathology
Clinical and Vaccine Immunology, Vol. 19, Núm. 2, pp. 167-173
-
Trypanosoma cruzi paraflagellar rod proteins 2 and 3 contain immunodominant CD8+ T-cell epitopes that are recognized by cytotoxic T cells from Chagas disease patients
Molecular Immunology, Vol. 52, Núm. 3-4, pp. 289-298
2011
-
Identification of HLA-A*02:01-restricted CTL epitopes in Trypanosoma cruzi heat shock protein-70 recognized by Chagas disease patients
Microbes and Infection, Vol. 13, Núm. 12-13, pp. 1025-1032
-
Short-term follow-up of chagasic patients after benznidazole treatment using multiple serological markers
BMC Infectious Diseases, Vol. 11